Target intelligence / Profile preview

Ribosomal L24 domain containing 1 pseudogene 5 (RSL24D1P5)

Target
RSL24D1P5
Molecular classification
Pseudogene, Other
01

Overview

Ribosomal L24 domain containing 1 pseudogene 5 (RSL24D1P5) is a human pseudogene, designated and approved by the HUGO Gene Nomenclature Committee (HGNC:37870), located in the human genome. Pseudogenes are segments of DNA similar to known genes but typically lack the ability to encode functional proteins due to mutations or truncations. RSL24D1P5 shows homology to the gene encoding ribosomal protein L24, but as a pseudogene, it does not produce a functional protein and is not considered a receptor, enzyme, transporter, or direct drug target. While there is growing evidence that pseudogenes can play roles in gene regulation—such as acting as competing endogenous RNAs or regulatory elements—no specific function, disease involvement, or interaction is yet attributed to RSL24D1P5. It is not referenced as a therapeutic target or physiological driver in current scientific or medical resources.

02

Mechanism of action

None established for this pseudogene.

03

Biological functions

As a pseudogene, likely lacks direct biological activity; may participate in post-transcriptional regulation as a non-coding RNA, potentially acting as a microRNA decoy, competitor for RNA-binding proteins, or source of regulatory RNAs, by analogy with other pseudogenesNo specific biological function assigned
04

Disease associations

Not associated directly with known disease roles.Some pseudogenes may modulate gene expression in cancer and other diseases by regulatory RNA mechanisms. No evidence for RSL24D1P5 specifically.

Beyond the preview

Go deeper on Ribosomal L24 domain containing 1 pseudogene 5 (RSL24D1P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal L24 domain containing 1 pseudogene 5 (RSL24D1P5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call